Clinical trial
A Randomized, Parallel-Group, Assessor-Blind, Multi-Center, Non-Inferiority Pivotal Study to Evaluate the Efficacy and Safety of the Digital Therapeutics 'Repeech' for the Post-Stroke Dysarthria.
NCT06670014 is registered in ClinicalTrials.gov with HAII corp.ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Parallel-Group, Assessor-Blind, Multi-Center, Non-Inferiority Pivotal Study to Evaluate the Efficacy and Safety of the Digital Therapeutics 'Repeech' for the Post-Stroke Dysarthria.
- Lead sponsor
- HAII corp.ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 20, 2024
- Completion date
- November 14, 2025
- Enrollment
- 108 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
post-stroke dysarthria